Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
Methods Mol Biol. 2024;2711:77-88. doi: 10.1007/978-1-0716-3429-5_7.
The blood-brain barrier (BBB) plays an essential role in maintaining the homeostasis of the brain microenvironment by controlling the influx and efflux of biological substances that are necessary to sustain the neuronal metabolic activity and functions. This barrier is established at the blood-brain interface of the brain microcapillaries by different cells. These include microvascular endothelial cells, astrocytes, and pericytes besides other components such as microglia, basal membrane, and neuronal cells forming together what is commonly referred to as the neurovascular unit; different in vivo and in vitro platforms are available to study the BBB where each system provides specific benefits and drawbacks. Recently, organ-on-a-chip platforms combine the elegance of microengineering technology with the complexity of biological systems to create near-ideal experimental models for various diseases and organs. These microfluidic devices with micron-sized channels allow the cells to be grown in a more biologically relevant environment, enabling cell to cell communications with continuous bathing in biological fluids in a tissue-like fashion. They also closely represent tissue and organ functionality by recapitulating mechanical forces as well as vascular perfusion. Here, we describe the use of humanized BBB model created with microfluidic organ-on-a-chip technology where human brain microvascular endothelial cells (BMECs) are cocultured with primary human pericytes and astrocytes. We thoroughly described the method to assess BBB integrity using a microfluidic chip and various sizes of labeled dextran as permeability markers. In addition, we provide a detailed protocol on how to microscopically investigate the tight junction proteins expression between hBMECs.
血脑屏障(BBB)通过控制流入和流出维持脑微环境的稳态,这些物质对于维持神经元代谢活动和功能是必需的。这个屏障是由不同的细胞在脑微血管的血液-脑界面上建立的。这些细胞包括微血管内皮细胞、星形胶质细胞和周细胞,除此之外还有其他成分,如小胶质细胞、基底膜和神经元细胞,共同构成了通常所说的神经血管单元;有不同的体内和体外平台可用于研究 BBB,每个系统都提供了特定的优点和缺点。最近,器官芯片平台将微工程技术的优雅与生物系统的复杂性相结合,为各种疾病和器官创建了近乎理想的实验模型。这些具有微米级通道的微流控装置允许细胞在更具生物学相关性的环境中生长,以组织样的方式连续用生物流体浸泡实现细胞间通讯。它们还通过再现机械力和血管灌注来紧密模拟组织和器官的功能。在这里,我们描述了使用微流控器官芯片技术创建的人源化 BBB 模型,其中人脑微血管内皮细胞(BMEC)与人源周细胞和星形胶质细胞共培养。我们详细描述了使用微流控芯片评估 BBB 完整性的方法,以及各种大小的标记葡聚糖作为通透性标记物。此外,我们还提供了一个详细的方案,介绍如何在显微镜下研究 hBMEC 之间紧密连接蛋白的表达。